<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ascptpod.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>PSPod</title>
		<atom:link href="https://ascptpod.com/feed/podcast/pspod/" rel="self" type="application/rss+xml"/>
		<link>https://ascptpod.com/series/pspod/</link>
		<description>PSPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/21638306&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;CPT: Pharmacometrics &amp; Systems Pharmacology (PSP)&lt;/a&gt;. Join us as we delve into advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.</description>
		<lastBuildDate>Fri, 06 Mar 2026 12:00:13 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright>&#xA9; 2026 ASCPT Podcast Channel</copyright>
		<itunes:subtitle>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</itunes:subtitle>
		<itunes:author>ASCPT Podcast Channel</itunes:author>
		<itunes:summary>PSPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/21638306&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;CPT: Pharmacometrics &amp; Systems Pharmacology (PSP)&lt;/a&gt;. Join us as we delve into advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.</itunes:summary>
		<itunes:owner>
			<itunes:name>ASCPT Podcast Channel</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></itunes:image>
			<image>
				<url>https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png</url>
				<title>PSPod</title>
				<link>https://ascptpod.com/series/pspod/</link>
			</image>
		<itunes:category text="Science">
			<itunes:category text="Medicine"></itunes:category>
		</itunes:category>
		<googleplay:author><![CDATA[ASCPT Podcast Channel]]></googleplay:author>
						<googleplay:description>PSPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/21638306&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;CPT: Pharmacometrics &amp; Systems Pharmacology (PSP)&lt;/a&gt;. Join us as we delve into advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.</googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></googleplay:image>
			<podcast:locked>yes</podcast:locked>
		<podcast:guid>c4e69de6-1807-5d3f-9251-ff4301c0e69c</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.14.3" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.9.4</generator>

<item>
	<title>PSP Call for Papers: Pregnancy</title>
	<link>https://ascptpod.com/podcast/psp-call-for-papers-pregnancy/</link>
	<pubDate>Wed, 29 Nov 2023 14:00:53 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=316</guid>
	<description><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and ]]></itunes:subtitle>
	<content:encoded><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/316/psp-call-for-papers-pregnancy.mp3" length="7437358" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>PSP Call for Papers: Pregnancy</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:07</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Dose Finding in Oncology</title>
	<link>https://ascptpod.com/podcast/call-for-papers-dose-finding-in-oncology/</link>
	<pubDate>Mon, 03 Oct 2022 17:40:43 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=275</guid>
	<description><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &#38; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &#38; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology wi]]></itunes:subtitle>
	<content:encoded><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &#38; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/275/call-for-papers-dose-finding-in-oncology.mp3" length="4362585" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &#38; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: Dose Finding in Oncology</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:49</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &#38; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s the Best Way to Organize My Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-the-best-way-to-organize-my-review/</link>
	<pubDate>Mon, 20 Sep 2021 14:23:17 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=245</guid>
	<description><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharm]]></itunes:subtitle>
	<content:encoded><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/245/peer-review-whats-the-best-way-to-organize-my-review.mp3" length="5319141" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:27</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: After the Review</title>
	<link>https://ascptpod.com/podcast/peer-review-after-the-review/</link>
	<pubDate>Tue, 14 Sep 2021 11:00:44 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=242</guid>
	<description><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology details]]></itunes:subtitle>
	<content:encoded><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/242/peer-review-after-the-review.mp3" length="8257425" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: After the Review</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:53</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &#38; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSPod: Journal Submissions in the Time of COVID</title>
	<link>https://ascptpod.com/podcast/pspod-journal-submissions-in-the-time-of-covid/</link>
	<pubDate>Wed, 30 Sep 2020 13:35:53 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=225</guid>
	<description><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley ]]></itunes:subtitle>
	<content:encoded><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/225/pspod-journal-submissions-in-the-time-of-covid.mp3" length="100566" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png</url>
		<title>PSPod: Journal Submissions in the Time of COVID</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:28</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development</title>
	<link>https://ascptpod.com/podcast/midd_part_2/</link>
	<pubDate>Mon, 13 May 2019 14:29:40 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=200</guid>
	<description><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on ]]></itunes:subtitle>
	<content:encoded><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/200/midd_part_2.mp3" length="13879959" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:34</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PDUFA VI: It Is Time to Unleash the Full Potential  of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck</title>
	<link>https://ascptpod.com/podcast/pdufa-vi-it-is-time-to-unleash-the-full-potential-of-model-informed-drug-development/</link>
	<pubDate>Mon, 29 Apr 2019 19:46:38 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=197</guid>
	<description><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspec]]></itunes:subtitle>
	<content:encoded><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/197/pdufa-vi-it-is-time-to-unleash-the-full-potential-of-model-informed-drug-development.mp3" length="23693198" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:45</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Mathematical Biology Models of Parkinson’s Disease with guests Piet van der Graaf, Suruchi Bakshi, and Chao Chen</title>
	<link>https://ascptpod.com/podcast/mathematical-biology-models-parkinsons-disease-guests-piet-van-der-graaf-suruchi-bakshi-chao-chen/</link>
	<pubDate>Thu, 28 Mar 2019 19:50:58 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=193</guid>
	<description><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &#38; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &#38; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) mode]]></itunes:subtitle>
	<content:encoded><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &#38; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/193/mathematical-biology-models-parkinsons-disease-guests-piet-van-der-graaf-suruchi-bakshi-chao-chen.mp3" length="14404015" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &#38; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:00</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &#38; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Quantitative Systems Toxicology Modeling with guest Dr. Paul Watkins</title>
	<link>https://ascptpod.com/podcast/quantitative-systems-toxicology-modeling-guest-dr-paul-watkins/</link>
	<pubDate>Thu, 30 Aug 2018 16:01:05 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=188</guid>
	<description><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, disc]]></itunes:subtitle>
	<content:encoded><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/188/quantitative-systems-toxicology-modeling-guest-dr-paul-watkins.mp3" length="13967732" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:38</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Reverse Translation Special Joint Episode</title>
	<link>https://ascptpod.com/podcast/reverse-translation-special-joint-episode/</link>
	<pubDate>Thu, 08 Mar 2018 02:37:32 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=184</guid>
	<description><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Assoc]]></itunes:subtitle>
	<content:encoded><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/184/reverse-translation-special-joint-episode.mp3" length="22324853" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>18:36</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>&#8220;Thoughtflow&#8221; with guests Mike Smith, Justin Wilkins, and Amy Cheung</title>
	<link>https://ascptpod.com/podcast/thoughtflow-guests-mike-smith-justin-wilkins-amy-cheung/</link>
	<pubDate>Sat, 11 Nov 2017 02:10:41 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=179</guid>
	<description><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></description>
	<itunes:subtitle><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the]]></itunes:subtitle>
	<content:encoded><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/179/thoughtflow-guests-mike-smith-justin-wilkins-amy-cheung.mp3" length="21180665" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:39</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Pharmacometrics for Immuno-oncology with guest Iñaki F. Trocóniz</title>
	<link>https://ascptpod.com/podcast/pharmacometrics-immuno-oncology-guest-inaki-f-troconiz/</link>
	<pubDate>Wed, 19 Jul 2017 15:22:14 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=133</guid>
	<description><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here. Listen and subscribe for free on iTunes]]></description>
	<itunes:subtitle><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here. Listen and subscribe for free on iTunes]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/133/pharmacometrics-immuno-oncology-guest-inaki-f-troconiz.mp3" length="9766697" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here. Listen and subscribe for free on iTunes]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:08</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here. Listen and subscribe for free on iTunes]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Models of Blood Coagulation with guest Satyaprakash Nayak</title>
	<link>https://ascptpod.com/podcast/episode-4-models-blood-coagulation-guest-satyaprakash-nayak/</link>
	<pubDate>Fri, 04 Nov 2016 18:44:16 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=78</guid>
	<description><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to ]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/78/episode-4-models-blood-coagulation-guest-satyaprakash-nayak.mp3" length="49662029" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:39</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung</title>
	<link>https://ascptpod.com/podcast/good-practices-model-informed-drug-discovery-development-guests-scott-marshall-sandra-visser-amy-cheung/</link>
	<pubDate>Mon, 09 May 2016 20:00:15 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=107</guid>
	<description><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here. Listen and subscribe [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here. Listen and subscribe [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/107/good-practices-model-informed-drug-discovery-development-guests-scott-marshall-sandra-visser-amy-cheung.mp3" length="33003659" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here. Listen and subscribe [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>27:30</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here. Listen and subscribe [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Communicating Systems Pharmacology and Pharmacometrics Models with guest Peter Bonate</title>
	<link>https://ascptpod.com/podcast/communicating-systems-pharmacology-pharmacometrics-models-guest-peter-bonate/</link>
	<pubDate>Fri, 26 Feb 2016 19:47:55 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=75</guid>
	<description><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here. Listen and subscribe for free on iTunes and [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen L]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here. Listen and subscribe for free on iTunes and [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/75/communicating-systems-pharmacology-pharmacometrics-models-guest-peter-bonate.mp3" length="42729131" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here. Listen and subscribe for free on iTunes and [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:46</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here. Listen and subscribe for free on iTunes and [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Existing Practice to Modeling Approaches with guests Sandra Visser and Anne Chain</title>
	<link>https://ascptpod.com/podcast/existing-practice-modeling-approaches-guests-sandra-visser-anne-chain/</link>
	<pubDate>Fri, 15 Jan 2016 19:45:39 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=77</guid>
	<description><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &#38; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here. [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &#38; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &#38; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here. [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/77/existing-practice-modeling-approaches-guests-sandra-visser-anne-chain.mp3" length="49662029" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &#38; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here. [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:39</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &#38; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here. [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Drug Disease Resources Consortium with guest Lutz Harnisch</title>
	<link>https://ascptpod.com/podcast/drug-disease-resources-consortium-guest-lutz-harnisch/</link>
	<pubDate>Fri, 18 Sep 2015 18:46:41 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=76</guid>
	<description><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found h]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/76/drug-disease-resources-consortium-guest-lutz-harnisch.mp3" length="34889262" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:30</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Databases as Tools in Pharmacometrics and Systems Pharmacology with guest Shiew-Mei Huang</title>
	<link>https://ascptpod.com/podcast/databases-as-tools-in-pharmacometrics-and-systems-pharmacology/</link>
	<pubDate>Mon, 01 Jun 2015 20:00:33 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=105</guid>
	<description><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of r]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/105/databases-as-tools-in-pharmacometrics-and-systems-pharmacology.mp3" length="8381681" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>6:59</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Infectious Diseases and the Role of Pharmacometrics with guest Steven E. Kern</title>
	<link>https://ascptpod.com/podcast/infectious-diseases-role-pharmacometrics-guest-steven-e-kern/</link>
	<pubDate>Mon, 02 Mar 2015 21:00:09 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=106</guid>
	<description><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to i]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/106/infectious-diseases-role-pharmacometrics-guest-steven-e-kern.mp3" length="9690937" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:04</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
